ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Business trends

No lab monkey? Japan Inc waits eagerly for China goods to return

Earnings downgrades look inevitable for many companies

A monkey cloned from a gene-edited macaque with circadian rhythm disorders is seen in a lab at the Institute of Neuroscience of Chinese Academy of Sciences in Shanghai.   © Reuters

TOKYO -- Trans Genic, a gene analysis company that carries out preclinical trials for pharmaceutical companies, has downgraded its fiscal 2019 earnings due to the coronavirust epidemic in China. 

The company has been unable to import lab monkeys from China it uses for contract trials due to customs restrictions following the outbreak. 

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more